Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris
- 31 May 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 26 (5) , 736-743
- https://doi.org/10.1016/0190-9622(92)70103-m
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Will 1,25-Dihydroxyvitamin D3, MC 903, and Their Analogues Herald a New Pharmacologic Era for the Treatment of Psoriasis?Archives of Dermatology, 1989
- USE OF CYCLOSPORIN IN PSORIASISThe Lancet, 1989
- A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisJournal of the American Academy of Dermatology, 1988
- Skin as the Site of Vitamin D Synthesis and Target Tissue for 1,25-Dihydroxyvitamin D3Archives of Dermatology, 1987
- An open study of vitamin D3 treatment in psoriasis vulgarisBritish Journal of Dermatology, 1986
- Successful treatment of psoriasis with topical application of active vitamin D3 analogue, 1α, 24-dihydroxycholecalciferolBritish Journal of Dermatology, 1986
- Clearance of psoriasis with low dose cyclosporin.BMJ, 1986
- Effect of 1α,25-Dihydroxyvitamin D3 on the Morphologic and Biochemical Differentiation of Cultured Human Epidermal Keratinocytes Grown in Serum-Free ConditionsJournal of Investigative Dermatology, 1986
- Interaction of 1,25-Dihydroxyvitamin-D3with Keratinocytes and Fibroblasts from Skin of Normal Subjects and a Subject with Vitamin-D-Dependent Rickets, Type II: A Model for Study of the Mode of Action of 1,25-Dihydroxyvitamin D3*Journal of Clinical Endocrinology & Metabolism, 1983
- DEMONSTRATION OF 1,25-DIHYDROXYVITAMIN D3RECEPTORS IN HUMAN SKIN BIOPSIESJournal of Clinical Endocrinology & Metabolism, 1980